NEW YORK (Thomson Financial) - Cadence Pharmaceuticals Inc. Friday said it
would privately sell 9.2 million common shares for $5.34 a share to unnamed
investors in a registered stock offering.
The company sees proceeds of up to $49.3 million from the offering, which
will close on Feb. 20.
Because of Nasdaq marketplace rules, the company said, it might lower the
number of shares offered to 8.1 million, which would result in proceeds of up to
$43 million.
Shares of the San Diego-based pharmaceutical closed Thursday at $5.34.
Ryan Vlastelica
rv/tk1
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|